Literature DB >> 2043021

Zirconium compound-induced pulmonary fibrosis.

T Bartter1, R S Irwin, J L Abraham, A Dascal, G Nash, J S Himmelstein, P J Jederlinic.   

Abstract

Despite suspicion that inhalation of zirconium should be capable of causing human pulmonary disease, documentation of zirconium pneumoconiosis in humans has been lacking. We studied a likely case of zirconium compound-induced pulmonary fibrosis. The diagnosis was based on the following: (1) a history of gradual increase in symptoms and slowly progressing pulmonary fibrosis by chest roentgenogram compatible with a pneumoconiosis; (2) an appropriate history of exposure and a latency period of about 15 years before the onset of dyspnea and of roentgenographic changes; (3) analysis of open lung biopsy material revealing end-stage fibrosis and honeycombing, a moderate number of birefringent particles, and extremely high levels of a variety of zirconium compounds; and (4) no other potential cause of fibrosis. We conclude that zirconium should be considered a likely cause of pneumoconiosis and that appropriate precautions should be taken in the workplace.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2043021

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  2 in total

1.  Hypersensitivity pneumonitis presenting as sarcoidosis.

Authors:  L S Forst; J Abraham
Journal:  Br J Ind Med       Date:  1993-06

2.  State-Level Health Disparity Is Associated with Sarcoidosis Mortality.

Authors:  Yu-Che Lee; Ko-Yun Chang; Mehdi Mirsaeidi
Journal:  J Clin Med       Date:  2021-05-27       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.